Autolus Therapeutics (AUTL) Receivables - Net (2022 - 2025)

Autolus Therapeutics' Receivables - Net history spans 4 years, with the latest figure at $24.0 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 159900.0% year-over-year to $24.0 million; the TTM value through Dec 2025 reached $24.0 million, up 159900.0%, while the annual FY2025 figure was $24.0 million, 159900.0% up from the prior year.
  • Receivables - Net reached $24.0 million in Q4 2025 per AUTL's latest filing, down from $32.6 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $32.6 million in Q3 2025 to a low of $15000.0 in Q4 2024.
  • Average Receivables - Net over 4 years is $12.2 million, with a median of $7.2 million recorded in 2023.
  • Peak YoY movement for Receivables - Net: crashed 86.24% in 2024, then surged 159900.0% in 2025.
  • A 4-year view of Receivables - Net shows it stood at $121000.0 in 2022, then decreased by 9.92% to $109000.0 in 2023, then plummeted by 86.24% to $15000.0 in 2024, then soared by 159900.0% to $24.0 million in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Receivables - Net are $24.0 million (Q4 2025), $32.6 million (Q3 2025), and $26.6 million (Q2 2025).